Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96.
Wang J, Grishin AV, Ford HR
J Immunol. 2016 Jun 15;196(12):5130-7. doi: 10.4049/jimmunol.1502135. Epub 2016 May 18.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.